DDI vs. ASTH, DFIN, GDRX, XMTR, APLD, PINC, NEO, PHR, STGW, and UPBD
Should you be buying DoubleDown Interactive stock or one of its competitors? The main competitors of DoubleDown Interactive include Astrana Health (ASTH), Donnelley Financial Solutions (DFIN), GoodRx (GDRX), Xometry (XMTR), Applied Digital (APLD), Premier (PINC), NeoGenomics (NEO), Phreesia (PHR), Stagwell (STGW), and Upbound Group (UPBD). These companies are all part of the "business services" industry.
DoubleDown Interactive vs.
DoubleDown Interactive (NASDAQ:DDI) and Astrana Health (NASDAQ:ASTH) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.
DoubleDown Interactive has higher earnings, but lower revenue than Astrana Health. DoubleDown Interactive is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.
DoubleDown Interactive received 3 more outperform votes than Astrana Health when rated by MarketBeat users. Likewise, 84.21% of users gave DoubleDown Interactive an outperform vote while only 81.25% of users gave Astrana Health an outperform vote.
In the previous week, DoubleDown Interactive and DoubleDown Interactive both had 7 articles in the media. Astrana Health's average media sentiment score of 0.00 beat DoubleDown Interactive's score of -0.50 indicating that Astrana Health is being referred to more favorably in the news media.
DoubleDown Interactive has a net margin of 36.37% compared to Astrana Health's net margin of 3.63%. DoubleDown Interactive's return on equity of 15.52% beat Astrana Health's return on equity.
DoubleDown Interactive currently has a consensus price target of $21.67, suggesting a potential upside of 117.54%. Astrana Health has a consensus price target of $63.00, suggesting a potential upside of 76.57%. Given DoubleDown Interactive's stronger consensus rating and higher probable upside, equities research analysts clearly believe DoubleDown Interactive is more favorable than Astrana Health.
52.8% of Astrana Health shares are owned by institutional investors. 8.5% of Astrana Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
DoubleDown Interactive has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500. Comparatively, Astrana Health has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500.
Summary
DoubleDown Interactive and Astrana Health tied by winning 9 of the 18 factors compared between the two stocks.
Get DoubleDown Interactive News Delivered to You Automatically
Sign up to receive the latest news and ratings for DDI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
DoubleDown Interactive Competitors List
Related Companies and Tools
This page (NASDAQ:DDI) was last updated on 2/22/2025 by MarketBeat.com Staff
